[Phase II trial of concomitant cyclic radio-chemotherapy combination (ARCCC) in unoperable non-small cell lung cancer (CBNPCI)].
Vannetzel
J M
JM
Clinique Hartmann, Neuilly-Sur-Seine, France.
Rebischung
J L
JL
Chapelier
A
A
Dartevelle
P
P
Sauvaget
J
J
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000532:radiotherapy; D002945:Cisplatin / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D011829:Radiation Dosage; D014751:Vindesine / Q000627:therapeutic use*
D002945:Cisplatin; D014751:Vindesine; D005472:Fluorouracil
Essai de phase II par association radio-chimiothérapie concomitante cyclique (ARCCC) dans les cancers bronchiques non à petites cellules inopérables (CBNPCI).